Product
FX201
1 clinical trial
2 indications
Indication
OsteoarthritisIndication
KneeClinical trial
An Open-Label, Single Ascending Dose Study to Assess the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the KneeStatus: Active (not recruiting), Estimated PCD: 2023-11-28